Biovica will attend the 7th World Companion Diagnostic in Boston, October 18-21. The focus of the meeting is aligned with Biovicas strategy to rapidly progress exploratory biomarkers to registration, align clinical co-development and ensure reimbursement and market access success for precision therapies and assays. “At the World CDx meeting we look forward to meet partners [...]
Anders Rylander, CEO and Mattias Bergqvist,VP Marketing & Clinical Development presented Biovica at an investors meeting at the IVA conference center in Stockholm. The meeting was arranged by Vator Securities. See below for the full presentation. (Swedish).
Biovica will give a company presentation at the annual Unicorn Summit Capital Market Day. The summit gathers some of the most interesting and innovative companies in Sweden and is arranged annually by Vator Securities AB. In addition to company presentations, the 150 attendees and participants have the opportunity to network with industry peers as well [...]
Styrelsen i Biovica International AB, org.nr 556774-6150, kallar härmed till årsstämma. Kallelsen i sin helhet kan läsas på länkad sida (länk) NOTICE OF ANNUAL GENERAL MEETING 2016 Biovica's shareholders are invited to the annual general meeting 2016. Shareholders meeting 2016 (link)